Polypore (PPO) Reports In-Line Q4 EPS, Revenue Misses
Tweet
Share
E-mailGet Alerts PPO Hot Sheet
Price: $60.48 --0%
Financial Fact:
Selling, general and administrative expenses: 34.65M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Selling, general and administrative expenses: 34.65M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Polypore (NYSE: PPO) reported Q4 EPS of $0.45, in-line with the analyst estimate of $0.45. Revenue for the quarter came in at $165.2 million versus the consensus estimate of $176 million.
For earnings history and earnings-related data on Polypore (PPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Ascendis Pharma (ASND) Tops Q2 EPS by 132c
- Intuitive Machines, Inc. (LUNR) Misses Q2 EPS by 20c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
